Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Epidemiology > Global health: infectious disease and AIDS: history and progression > Flashcards

Global health: infectious disease and AIDS: history and progression Flashcards

1
Q

When do we think the first case of HIV occurred in the UK

A

Manchester, 1959.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What was the significance of the post mortem

A

The post mortem showed:
Pneumocystis carinii pneumonia (PCP)
cytomegalovirus (CMV) infection
These conditions had never been previously reported in adults

The case was reported as a rare condition and never referred to for more than 20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What was HIV first referred to as

A

By April 1981 the doctor had seen 5 men with a similar illness.
They were all in their early 30s, white and gay.
By June a report was published about this curious new health problem among homosexual men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the point of epidemiology

A

To track the presence of new diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the purpose of Centre of Disease and Control

A

Way of reporting notifiable diseases, centralised reporting system, allows us to evaluate the scale of the problem.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What was the initial hypothesis for patients with GRID

A 
An environmental factor?
bad batch of drugs
inhaled nitrates (poppers)
An infectious disease
a new virus
a strange combination of existing agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is meant by case collecting

A

Go round hospitals asking healthcare professionals whether they have seen patients that fit their criteria, allows us to monitor its progress and potentially its cause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How many people had HIV in the USA in 2006

A

1.3 million

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some of the factors for HIV

A

Male-to-male sexual contact
Intravenous drug use
Male-to-male sexual contact and IDU
High risk heterosexual contact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is meant by the case

A

A person living with said condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do we perform a case-control study

A

Identify cohort of cases, and cohort of people without the case.
Try to identify what is different, which may indicate to what is causing the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What did the initial case-control study with HIV show

A

75% of living cases were interviewed, along with controls for each patient
Asked about all possible exposures
sexual, medical, chemicals, pets, plants….
Results
Cases had twice as many sexual partners, and partners also had more partners
Cases had more history of syphilis
No association with “poppers”

The only main common factor was the disease was seen amongst young gay men and seemed to be related to sexual contact with each other- called CASE CLUSTERING- suggesting infectious agents
It was called GRID- Gay related Immune deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is meant by a case-control study

A

A case control studies sets out a known outcome and compares individuals with or without this outcome and determines what connects them. e.g. post op infections over a given time of an outbreak cases: knee op with infection controls knee op no infection. They are retrospective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do we design a case-control study

A

a case-control study is always retrospective because it starts with an outcome then traces back to investigate exposures. A case-control study is designed to help determine if an exposure is associated with an outcome (i.e., disease or condition of interest).
First, identify the cases (a group known to have the outcome) and the controls (a group known to be free of the outcome). Then, look back in time to learn which subjects in each group had the exposure(s), comparing the frequency of the exposure in the case group to the control group.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the advantages of case-control studies

A

cheap, quick, good for investigating outbreaks fo infectious diseases. Ideal to study RARE disease. Possibility to collect detailed clinical history.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the disadvantages of case-control studies

A

o Possible bias in control selection. o Bias in exposure assessment (e.g. recall bias). o Uncertainty in exposure to disease temporal relationship. o Cannot estimate disease incidence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the clustering of cases in HIV

A

Clustering of cases
Bill Darrow
“It looks more like a sexually transmitted disease than syphilis”

BUT then not all cases were amongst gay men:
Cases in injecting drug users & transfusion/Factor VIII recipients

10 women with the disease, all had sex with bisexual men or drug users

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the detective work involved in HIV

A

A number of early patients happened to mention being friends with an air steward from Canada
Investigators asked patients to name all their sexual partners
Nine of first 19 cases in Los Angeles were sexually linked to the airline steward
Several gay men presenting with sickness were or had been sexual partners
Apparent long incubation period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the evidence linked with HIV

A

Cases with clear source of infection
monogamous sexual partners of affected people
babies transfused at birth
Haemophiliacs received contaminated blood products
Finding the virus - 1983
Testing for the virus - 1984- TAKES TIME TO DEVELOP WIDEPREAD ACCURATE TESTS
retrospective testing of stored sera
1978 <1% positive
1980 20% positive

NO TREATMENT

20
Q

How is HIV transmitted

A

Transmission through body fluids: sexual contact , breast feeding or blood

21
Q

Where does the majority of the burden of HIV lie

A

90% of disease in developing countries

22
Q

Define prevalence

A

The frequency of a disease in a population at a point in time

= number of cases in population
number of people in population

23
Q

What is prevalence used for

A

Prevalence measures burden of disease in a population
It is useful for planning
It can be used to compare burden of chronic disease between populations

24
Q

How many people are currently living with HIV

A

36.9 million [31.1 million–43.9 million] people globally were living with HIV in 2017.

25
Q

What is the mortality of HIV/AIDS

A

1 million deaths a year

26
Q

Define incidence

A

The number of new infections within a population over time within a certain defined population.
Usually defined annually.

27
Q

How do we reduce prevalence

A

By reducing incidence- hasn’t been reduced much worldwide, but UK is seeing larger reductions.

28
Q

Where are the majority of new diagnoses of HIV in the UK from

A

the UK, we are lacking a prevention strategy.

29
Q

What is the key target for WHO

A

No new infections
No new babies infected- ONLY CUBA has achieved this, universal screening, prevention given to those infected.
No more HIV related deaths globally

30
Q

How do we estimate incidence

A

Need to define the time period under question
Need to define the denominator; what is the total population at risk; for this example it is all the people living in Sierra Leone during this time period
Need an accurate test to define a true case; a blood test for Ebola is either positive or negative and if it was newly positive this suggests a new case or incident infection. This is easy to do for infections that have a short time period but what for chronic infections eg HIV where a positive antibody test does not always mean it is a new infection ?

31
Q

How can incidence influence policy

A

in the case of Ebola once incidence has reached near zero we declare the outbreak over and can reopen schools etc

32
Q

Define mortality

A

Number of deaths from a disease in a population over a given time (usually annually).

= Deaths from disease in a given time period
population at start of time period

33
Q

How many people died from AIDS in 2017

A

940 000 [670 000–1.3 million] people died from AIDS-related illnesses in 2017.

34
Q

When is the epidemic stable

A

If mortality = incidence the epidemic is stable

The burden globally is the same

35
Q

How can prevalence increase, even if mortality decreases

A

If we keep more people alive with ART then the mortality reduces and potentially people are alive longer

As mortality goes down more people are alive and live longer they can:

transmit virus to sexual partners and their babies and incidence may go up
prevalence increases as more cases are transmitted as well as people not dying
Need to reduce incidence,

36
Q

Explain the relationship between mortality and prevalence

A

Define prevalence and mortality
For diseases where treatment confers survival benefit (eg ART for people living with HIV) the mortality falls as people start ART. Hence these people survive and overall population level prevalence increases.
For diseases that are rapidly fatal (eg Ebola) the mortality is rapid and high and so large number of cases but overall prevalence is low.

37
Q

What do prevention tools depend on

A

How the disease spreads, and life span of person infected with that pathogen.

38
Q

How can we explain that as prevalence increases incidence can reduce in the setting of HIV infection?

A 
Antiretroviral therapy (ART) improves survival of people living with HIV as more people living with HIV receive ART (15 million people globally are on ART) the prevalence of HIV within a population increases.
ART also reduces the risk of onward viral transmission by limiting the level of virus in the blood and secretions of people living with HIV to almost zero (HPTN052, PARTNER study, PMTCT studies). Therefore the more people taking ART the less people within a population transmit infection and so incidence reduces.
39
Q

What were the objectives of IAS 2010

A

i) Recognize and use HIV treatment as a tool for preventing new infections
ii) Develop better combination antiretroviral medications and cheaper diagnostics tools
iii) Find ways to lower other HIV-related costs
iv) Expand the availability of HIV testing and build stronger links between HIV testing and care
v) Encourage and support community leadership in expanding and improving local HIV responses.

40
Q

Why may people not take HIV tests

A

Stigma, issues with obtaining ART- human nature interferes with our ability to get to zero.

41
Q

What does risk of passing HIV onto sexual partner depend on

A

Viral load

42
Q

Where are the gaps in HIV treatment

A

Young men and women
Migrants
People not linked into care, and with transient sexual partners.

43
Q

What are the 6 leading causes of deaths in low income countries

A 
Lower Respiratory tract infection
Diarrhoea
HIV/AIDS
Ischaemic heart disease
Malaria
Stroke CVD
TB
44
Q

What were the top 10 global causes of death in 2016

A

Ischaemic heart disease

Stroke
COPD

Lower Respiratory tract infections
Alzheimer disease and other dementias
Trachea, bronchus, lung cancers
Diabetes mellitus
Road injury
Diarrhoeal diseases
TB
45
Q

What are the 6 leading causes of deaths due to infectious disease

A
  1. Lower respiratory Tract infections Liam 2. HIV/AIDS Had 3. Diarrhoeal Diseases Diarrhoea 4. TB That 5. Malaria Made 6. Measles

Epidemiology (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions